PlexBio Co., Ltd. (TPEX:6572)

PlexBio Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	145.8	191.04	266.53	278.87	310.36	348.28
Short-Term Investments	137.4	137.4	149	149	169	213.5
Cash & Short-Term Investments	283.2	328.44	415.53	427.87	479.36	561.78
Cash Growth	-16.36%	-20.96%	-2.89%	-10.74%	-14.67%	-14.13%
Accounts Receivable	25.9	1.39	2.61	0.54	1.87	4.47
Other Receivables	4.84	5.22	6.89	10.9	14.53	28.65
Receivables	30.74	6.6	9.5	11.44	16.4	33.12
Inventory	57.62	75.77	68.7	30.33	37.64	50.28
Prepaid Expenses	1.97	2.09	41.42	7.66	10.05	34.9
Other Current Assets	-	4.01	1.18	1.26	4.5	4.8
Total Current Assets	373.53	416.91	536.33	478.56	547.94	684.87
Property, Plant & Equipment	14.06	21.06	23.82	29.99	27.3	38.94
Long-Term Investments	3.67	6.19	8.46	4.01	2.56	5.33
Other Intangible Assets	0.17	0.24	0.43	0.69	0.72	0.47
Other Long-Term Assets	2.21	2.2	3.33	3.42	3.62	3.2
Total Assets	393.64	446.59	572.38	516.66	582.15	732.8

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	5.59	3.09	9.86	2.46	2.77	3.26
Accrued Expenses	9.74	12.04	12.46	18.25	12.42	17.37
Current Portion of Leases	4.82	8.23	3.36	8.42	3.8	7.77
Current Unearned Revenue	65.89	88.81	137.12	19.48	17.78	104.18
Other Current Liabilities	4.25	4.47	6.12	5.93	9.51	12.03
Total Current Liabilities	90.28	116.63	168.92	54.53	46.29	144.61
Long-Term Leases	0.42	1.34	2.31	2.44	2.22	1.38
Long-Term Unearned Revenue	13.9	18.18	26.74	35.29	43.85	52.49
Other Long-Term Liabilities	-	-	-	-	10.37	-
Total Liabilities	104.6	136.15	197.97	92.26	102.72	198.48

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	1,036	1,036	1,036	1,036	1,036	1,036
Additional Paid-In Capital	638.38	619.48	619.48	635.53	633.24	632.7
Retained Earnings	-1,358	-1,339	-1,276	-1,213	-1,155	-1,102
Comprehensive Income & Other	-27.51	-6.72	-5.21	-34.4	-35.61	-33.31
Shareholders' Equity	289.04	310.44	374.41	424.4	479.43	534.32
Total Liabilities & Equity	393.64	446.59	572.38	516.66	582.15	732.8

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	5.23	9.56	5.67	10.85	6.02	9.15
Net Cash (Debt)	277.97	318.87	409.86	417.02	473.33	552.63
Net Cash Growth	-14.43%	-22.20%	-1.72%	-11.90%	-14.35%	-14.29%
Net Cash Per Share	2.68	3.08	3.95	4.02	4.57	5.34
Filing Date Shares Outstanding	103.65	103.65	103.65	103.65	103.65	103.65
Total Common Shares Outstanding	103.65	103.65	103.65	103.65	103.65	103.65
Working Capital	283.25	300.28	367.41	424.03	501.66	540.27
Book Value Per Share	2.79	3.00	3.61	4.09	4.63	5.16
Tangible Book Value	288.87	310.21	373.98	423.71	478.71	533.85
Tangible Book Value Per Share	2.79	2.99	3.61	4.09	4.62	5.15
Machinery	107.95	107.25	121.34	112.24	105.48	102.81
Construction In Progress	-	-	-	-	-	0.14
Leasehold Improvements	30.01	29.3	29.23	28.51	28.8	28.43

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 13, 2026

Data Sources Report a data error